desmethylselegiline has been researched along with buthionine sulfoximine in 2 studies
| Studies (desmethylselegiline) | Trials (desmethylselegiline) | Recent Studies (post-2010) (desmethylselegiline) | Studies (buthionine sulfoximine) | Trials (buthionine sulfoximine) | Recent Studies (post-2010) (buthionine sulfoximine) |
|---|---|---|---|---|---|
| 42 | 12 | 1 | 2,460 | 8 | 408 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, G; Han, SK; Heinonen, EH; Leonardi, EK; Mytilineou, C; Olanow, CW; Radcliffe, P; Werner, P | 1 |
| Barna, G; Magyar, K; Szende, B | 1 |
2 other study(ies) available for desmethylselegiline and buthionine sulfoximine
| Article | Year |
|---|---|
Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion.
Topics: Amphetamines; Animals; Ascorbic Acid; Buthionine Sulfoximine; Cells, Cultured; Dose-Response Relationship, Drug; Glutathione; Mazindol; Mesencephalon; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Pargyline; Rats; Selegiline; Tyrosine 3-Monooxygenase | 1998 |
Cytoprotective effect of (-)-deprenyl, (-)desmethyl-deprenyl and (-)deprenyl-N-oxide on glutathione depleted A-2058 melanoma cells.
Topics: Amphetamines; Buthionine Sulfoximine; Cell Death; Cell Line, Tumor; Cytoprotection; Drug Interactions; Flow Cytometry; Glutathione; Humans; Melanoma; Monoamine Oxidase Inhibitors; Radiation-Sensitizing Agents; Selegiline; Serum | 2010 |